The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...
Asthma inhalers are one type of allergic asthma medication that can help when symptoms begin. Find out which other types of ...
I f, like me, you've been glued to your couch every Sunday night to catch the latest episode of The White Lotus, then you've ...
Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.
Louisiana has started monitoring abortion pills. Some other states are likely to follow suit. It could have disastrous ...
Scientists have found further evidence that long-term use of common over-the-counter pain medication such as aspirin and ...
The analysis, based on data from sources including the USP Medicine Supply Map, found that 71% of the drugs identified as the most vulnerable are injectables, including sodium chloride injection, ...
Some of the agencies affected include NOAA, the National Forest Service and the FDA across cities in California. But some details are less clear.
If you find medication side effect lists overwhelming, you’re not alone. Your doctor and medical care team can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results